Pulsenmore Ltd. (PLSM) stock
PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.41+0.03 (+2.17%)
Close on Nov 16, 2026Market cap $9.17MP/E 1.8Yield –
Pulsenmore r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was 17.35M ILS, down 13.8% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.35M ILS | -13.8% |
| FY2024 | Dec 31, 2024 | 20.13M ILS | -35.9% |
| FY2023 | Dec 31, 2023 | 31.40M ILS | – |
See a number that looks wrong?